Scientific Research

Dr. Peter Wilcox continues to push the field of Optometric Medicine and is looking to care for his patients with the latest technologies. To that end, Wilcox Eye Center is proud to be participating in a clinical trial with Dr. Peter Wilcox as the lead investigator.

Safety and Efficacy of Microcurrent Level Bioelectric Signaling in the Treatment of Age-Related Macular Degeneration

PURPOSE OF THE STUDY

This study aims to examine and validate the safety, efficacy and optimal sequencing for both previously

studied and novel bioelectric signals in the treatment of dry age related macular degeneration (D-AMD).

Simply put, this study will pass various electrical currents, which are typically too slight to sense, through

the eyes to assist those who suffer from dry macular degeneration. Most of the currents have already

been studied in the eyes. Subtleties, yet differences in terminologies and functions of the microcurrents

are termed as: frequency specific microcurrent (FSM) and bioelectric signals (BES). All have been

successfully used throughout the body and will now be similarly used for those with AMD.

In this document, you may see the terms “medication”, “treatment”, and “treatment period”; these are

terms used in research studies as mentioned above and does not mean that you will be receiving

medical treatment for any condition. These terms apply to the study device and parts of the study

where you will receive the investigational product.

HOW LONG THE STUDY WILL LAST AND HOW MANY PEOPLE WILL BE IN THE STUDY

This study will recruit 40 participants. Each participant’s involvement will be from 7 to 8 months.

● Two months of at-home medical food use (Ocufolin®)

● Three to four months (depending upon your group placement) of twice-a-week, approximately 1

hour of microcurrent exposure

● Two months of at-home medical food use (Ocufolin®)

Are you interested in being a participant in the study? – Patient Informed Consent

TO BE IN THIS STUDY

Subject Responsibilities:

While participating in this research study, you will need to:

Be willing and able to follow the study directions and procedures

Tell the study staff about any side effects or problems

Ask questions as you think of them

Tell the investigator or the study staff if you change your mind about staying in the study or clicking below:

Please download the full Patient Informed Consent information here or clicking below: